Biostar Report issue

For profit Phase 2 Phase 3
Founded: Beijing China (2002)
Status: No NME R&D (2002)

Organization Overview

First Clinical Trial
2007
NCT01302015
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Beijing Biostar Technologies, Ltd | Biostar | Chengdu Biostar Pharmaceuticals, Ltd